Omada is trading publicly after 14 years of providing support to patients with weight-related chronic illnesses. Leadership sees the current moment as the perfect time for an IPO, as GLP-1 drugs such ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...

The UK's MHRA have issued a warning to people on birth control who may also be taking drugs like Ozempic, Wegovy or Mounjaro ...

The petition, filed by Massachusetts, New York, California, and New Jersey, aims to compel the FDA to recognize that mifepristone is safe and effective. More reproductive health news includes GLP-1 ...

Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

Faith Hill and Tim McGraw have three daughters who all inherited their musical prowess. Learn about the grown-up girls here.